Maine consumers who bought certain generic drugs between May 2009 and December 2019 may be eligible for compensation under a multistate settlement with drug manufacturers.
Maine Attorney General Aaron Frey is urging Maine residents to check their eligibility for compensation under a distribution plan filed by Maine and a coalition of 47 other states and territories.
Earlier this month, the U.S. District Court for the District of Connecticut granted preliminary approval to the plan, which would distribute settlement funds paid by generic drug manufacturers in exchange for resolving claims that the companies illegally conspired to raise the prices of generic drugs.
The coalition previously announced settlements with the manufacturers Glenmark, Lannett, Bausch, Apotex and Heritage, as well as Heritage’s parent company, Emcure, totaling around $96.5 million.
The multistate coalition’s distribution plan aims to return millions of dollars from those settlement funds to consumers who may have been harmed by elevated prices for the generic drugs covered by the settlements.
More information
To determine your eligibility, call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com or visit https://www.AGGenericDrugs.com
The deadline for submitting a claim is March 8, 2027.
